Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials

Publisher： Karger

E-ISSN： 1423-0208|44|1|16-23

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.44, Iss.1, 2015-01, pp. : 16-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is Interferon Effective and Safe for Relapsing-Remitting Multiple Sclerosis?

By  

Neuroepidemiology, Vol. 21, Iss. 6, 2002-11 ,pp. : 310-

Karger

Access to resources Recommend Favorite

The Prognostic Value of Initial Relapses on the Evolution of Disability in Patients with Relapsing-Remitting Multiple Sclerosis

By  

Neuroepidemiology, Vol. 27, Iss. 1, 2006-07 ,pp. : 45-54

Karger

Access to resources Recommend Favorite

Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study

By  

European Neurology, Vol. 72, Iss. 3-4, 2014-09 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait

By  

Medical Principles and Practice, Vol. 22, Iss. 5, 2013-06 ,pp. : 495-499

Karger

Access to resources Recommend Favorite

New Hypointense Lesions on MRI in Relapsing-Remitting Multiple Sclerosis Patients

By  

European Neurology, Vol. 43, Iss. 4, 2000-05 ,pp. : 194-200

Karger

Access to resources Recommend Favorite